Imagenomix
New York, US · 3 known investors
Find your way into Imagenomix
Sign up to see every warm intro you have to Imagenomix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imagenomix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery. The company serves oncologists and pathologists seeking precision medicine insights for clinical decision-making.
Founders & leadership
AT

Aris TsirigosCo-Founder
MS
Matija SnuderlCo-Founder
DO

Daniel OrringerCo-Founder
TW

MT

Mikhail TeverovskiyChief Technology Officer
LK
Lizabeth KatsnelsonPrincipal AI Data Scientist
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeedMay 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Imagenomix do?
- Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery. The company serves oncologists and pathologists seeking precision medicine insights for clinical decision-making.
- Who founded Imagenomix?
- Imagenomix was founded by Aris Tsirigos, Matija Snuderl, Daniel Orringer.
- Who are Imagenomix's investors?
- Imagenomix's investors include Metavallon VC, Modi Ventures, Verge HealthTech Fund.
- Where is Imagenomix headquartered?
- Imagenomix is headquartered in New York, US.


